The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-11
DOI
10.3389/fonc.2020.583217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial TCA cycle metabolites control physiology and disease
- (2020) Inmaculada Martínez-Reyes et al. Nature Communications
- PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling
- (2020) Michelle K. Y. Siu et al. Oncogenesis
- STAT 3 ‐dependent analysis reveals PDK 4 as independent predictor of recurrence in prostate cancer
- (2020) Monika Oberhuber et al. Molecular Systems Biology
- Micromanaging aerobic respiration and glycolysis in cancer cells
- (2019) Ayla V. Orang et al. Molecular Metabolism
- Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma
- (2019) Surangkana Sanmai et al. Oncology Letters
- PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia
- (2019) Fabrizio Pin et al. FASEB JOURNAL
- High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases
- (2019) Moritz J. Strowitzki et al. BRITISH JOURNAL OF CANCER
- Zinc cooperates with p53 to inhibit the activity of mitochondrial aconitase through reactive oxygen species accumulation
- (2019) Ya‐Nan Xue et al. Cancer Medicine
- MicroRNA‐214 suppresses cell proliferation and migration and cell metabolism by targeting PDK2 and PHF6 in hepatocellular carcinoma
- (2019) Qiangfeng Yu et al. CELL BIOLOGY INTERNATIONAL
- miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3
- (2019) Lan Feng et al. BIOSCIENCE REPORTS
- Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
- (2019) Benjamin L. Woolbright et al. MOLECULAR CANCER THERAPEUTICS
- The Role of Glutaminase in Cancer
- (2019) Brendah K. Masisi et al. HISTOPATHOLOGY
- Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
- (2019) Yu Liang et al. ONCOGENE
- Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
- (2019) Tiziana Tataranni et al. Oxidative Medicine and Cellular Longevity
- The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer
- (2019) Wenjuan Qin et al. Scientific Reports
- Benzyl butyl phthalate (BBP) triggers the malignancy of acute myeloid leukemia cells via upregulation of PDK4
- (2019) Xian-Liang Duan et al. TOXICOLOGY IN VITRO
- Loss of PDK4 switches the hepatic NF-κB/TNF pathway from pro-survival to pro-apoptosis
- (2018) Jianguo Wu et al. HEPATOLOGY
- The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
- (2018) Benjamin L Woolbright et al. MOLECULAR CANCER THERAPEUTICS
- Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
- (2018) Jingjing Chen et al. NATURE GENETICS
- Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics
- (2018) Thomas W. Grunt TRENDS IN ENDOCRINOLOGY AND METABOLISM
- MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer
- (2018) Zhongyuan He et al. Cell Death & Disease
- Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
- (2018) Leena Latonen et al. Nature Communications
- PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels
- (2018) Bo-Yoon Park et al. DIABETES
- Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation
- (2018) Meng Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Discovery of potent pyruvate dehydrogenase kinases inhibitors and their anti-lung cancer activity evaluation under hypoxia
- (2018) Ronghua Yang et al. MedChemComm
- Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia
- (2018) Longzhen Cui et al. CANCER GENE THERAPY
- Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex
- (2018) Alla Klyuyeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
- (2018) Giorgia Zadra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer
- (2018) Jinghao Wang et al. Cancer Management and Research
- Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
- (2017) Peter W Stacpoole JNCI-Journal of the National Cancer Institute
- Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
- (2017) F Peng et al. ONCOGENE
- Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel
- (2017) Hong Sun et al. Oncotarget
- Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
- (2017) Peter W Stacpoole JNCI-Journal of the National Cancer Institute
- Glucose Metabolism in the Progression of Prostate Cancer
- (2017) Francesca Cutruzzolà et al. Frontiers in Physiology
- The Metabolic Phenotype of Prostate Cancer
- (2017) Eric Eidelman et al. Frontiers in Oncology
- The Warburg effect and drug resistance
- (2016) Bhaskar Bhattacharya et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer
- (2016) Jong-Lyel Roh et al. CANCER LETTERS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins
- (2016) Jonathan Choiniere et al. MOLECULAR PHARMACOLOGY
- The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis
- (2016) G Li et al. ONCOGENE
- PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer
- (2016) Tao Liu et al. ONCOLOGY REPORTS
- KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis
- (2016) Ling-Yu Wang et al. Cell Reports
- PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
- (2015) Fanny Dupuy et al. Cell Metabolism
- Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
- (2015) Wen Zhang et al. International Journal of Biological Sciences
- The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents
- (2015) Elise Saunier et al. INTERNATIONAL JOURNAL OF CANCER
- Dysregulated metabolism contributes to oncogenesis
- (2015) Matthew D. Hirschey et al. SEMINARS IN CANCER BIOLOGY
- Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
- (2015) Lijun Qin et al. Oncotarget
- Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells
- (2015) William Walter et al. SpringerPlus
- PDK4 Protein Promotes Tumorigenesis through Activation of cAMP-response Element-binding Protein (CREB)-Ras Homolog Enriched in Brain (RHEB)-mTORC1 Signaling Cascade
- (2014) Zhibo Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth
- (2014) Changliang Shan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex
- (2014) Jun Fan et al. MOLECULAR CELL
- The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
- (2014) Shuai Zhang et al. Nutrition & Metabolism
- The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
- (2014) In-Kyu Lee Diabetes & Metabolism Journal
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Regulation of pyruvate metabolism and human disease
- (2013) Lawrence R. Gray et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism
- (2013) Yi Xuan et al. EXPERIMENTAL CELL RESEARCH
- Genetic Inactivation of Pyruvate Dehydrogenase Kinases Improves Hepatic Insulin Resistance Induced Diabetes
- (2013) Rongya Tao et al. PLoS One
- Inactivation of the HIF-1 /PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants
- (2012) J. Kluza et al. CANCER RESEARCH
- Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
- (2012) HOON HUR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The effect of continuous and interval exercise on PGC-1α and PDK4 mRNA in type I and type II fibres of human skeletal muscle
- (2011) L. Wang et al. Acta Physiologica
- Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer
- (2011) Chun-Wun Lu et al. AMERICAN JOURNAL OF PATHOLOGY
- p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
- (2011) T. Contractor et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism
- (2011) Taro Hitosugi et al. MOLECULAR CELL
- Mitochondrial Mutations Contribute to HIF1 Accumulation via Increased Reactive Oxygen Species and Up-regulated Pyruvate Dehydrogenease Kinase 2 in Head and Neck Squamous Cell Carcinoma
- (2009) W. Sun et al. CLINICAL CANCER RESEARCH
- Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin
- (2009) Sara Connaughton et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
- (2008) S M Wigfield et al. BRITISH JOURNAL OF CANCER
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells
- (2008) Thomas McFate et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of Pyruvate Dehydrogenase Kinase-3 by Hypoxia-inducible Factor-1 Promotes Metabolic Switch and Drug Resistance
- (2008) Chun-Wun Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started